Condition: Pericarditis · Pericarditis Acute · Recurrent Pericarditis · Sponsor: Kiniksa Pharmaceuticals International, plc
This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.
This description comes directly from the study's public registry record.
Clinical Project Manager · 781-431-9100 · clinicaltrials@kiniksa.com
Always discuss trial participation with your own doctor first.
| Investigational Site 018 | Gilbert, Arizona, United States | Recruiting |
| Investigational Site 053 | Phoenix, Arizona, United States | Recruiting |
| Investigational Site 030 | Los Angeles, California, United States | Recruiting |
| Investigational Site 008 | San Francisco, California, United States | Recruiting |
| Investigational Site 044 | Santa Monica, California, United States | Recruiting |
| Investigational Site 058 | Ventura, California, United States | Recruiting |
| Investigational Site 016 | Westminster, Colorado, United States | Recruiting |
| Investigational Site 001 | Columbus, Georgia, United States | Withdrawn |
| Investigational Site 004 | Chicago, Illinois, United States | Recruiting |
| Investigational Site 014 | Indianapolis, Indiana, United States | Recruiting |
| Investigational Site 002 | Overland Park, Kansas, United States | Withdrawn |
| Investigational Site 043 | Baltimore, Maryland, United States | Recruiting |
+ 46 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07010159